Literature DB >> 17324973

Effectiveness of a once weekly double dose of etanercept in patients with juvenile idiopathic arthritis: a clinical study.

Femke H M Prince, Marinka Twilt, Nelleke C J A Jansen-Wijngaarden, Lisette W A van Suijlekom-Smit.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17324973      PMCID： PMC1954640          DOI： 10.1136/ard.2006.067629

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

1.  Population pharmacokinetic analysis and simulation of the time-concentration profile of etanercept in pediatric patients with juvenile rheumatoid arthritis.

Authors:  Dong-Seok Yim; Honghui Zhou; Mary Buckwalter; Ivan Nestorov; Carl C Peck; Howard Lee
Journal:  J Clin Pharmacol       Date:  2005-03       Impact factor: 3.126

Review 2.  Current management of juvenile idiopathic arthritis.

Authors:  Carol A Wallace
Journal:  Best Pract Res Clin Rheumatol       Date:  2006-04       Impact factor: 4.098

3.  Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis.

Authors:  Daniel J Lovell; Andreas Reiff; Olcay Y Jones; Rayfel Schneider; James Nocton; Leonard D Stein; Abraham Gedalia; Norman T Ilowite; Carol A Wallace; James B Whitmore; Barbara White; Edward H Giannini
Journal:  Arthritis Rheum       Date:  2006-06

4.  Patterns of clinical remission in select categories of juvenile idiopathic arthritis.

Authors:  Carol A Wallace; Bin Huang; Marcia Bandeira; Angelo Ravelli; Edward H Giannini
Journal:  Arthritis Rheum       Date:  2005-11

5.  Preliminary definition of improvement in juvenile arthritis.

Authors:  E H Giannini; N Ruperto; A Ravelli; D J Lovell; D T Felson; A Martini
Journal:  Arthritis Rheum       Date:  1997-07

6.  Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis.

Authors:  D van der Heijde; J C Da Silva; M Dougados; P Geher; I van der Horst-Bruinsma; X Juanola; I Olivieri; F Raeman; L Settas; J Sieper; J Szechinski; D Walker; M-P Boussuge; J S Wajdula; L Paolozzi; S Fatenejad
Journal:  Ann Rheum Dis       Date:  2006-09-12       Impact factor: 19.103

7.  Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group.

Authors:  D J Lovell; E H Giannini; A Reiff; G D Cawkwell; E D Silverman; J J Nocton; L D Stein; A Gedalia; N T Ilowite; C A Wallace; J Whitmore; B K Finck
Journal:  N Engl J Med       Date:  2000-03-16       Impact factor: 91.245

8.  Preliminary definition of disease flare in juvenile rheumatoid arthritis.

Authors:  Hermine I Brunner; Daniel J Lovell; Barbara K Finck; Edward H Giannini
Journal:  J Rheumatol       Date:  2002-05       Impact factor: 4.666

Review 9.  The German etanercept registry for treatment of juvenile idiopathic arthritis.

Authors:  G Horneff; H Schmeling; T Biedermann; I Foeldvari; G Ganser; H J Girschick; T Hospach; H I Huppertz; R Keitzer; R M Küster; H Michels; D Moebius; B Rogalski; A Thon
Journal:  Ann Rheum Dis       Date:  2004-04-28       Impact factor: 19.103

10.  Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

Authors:  Edward C Keystone; Michael H Schiff; Joel M Kremer; Shelly Kafka; Michael Lovy; Todd DeVries; Daniel J Burge
Journal:  Arthritis Rheum       Date:  2004-02
  10 in total
  7 in total

1.  Initiating etanercept in a once weekly dose in children with juvenile idiopathic arthritis.

Authors:  Femke H M Prince; Lisette W A van Suijlekom-Smit
Journal:  Rheumatol Int       Date:  2007-10-17       Impact factor: 2.631

Review 2.  The development and assessment of biological treatments for children.

Authors:  Eve M D Smith; Helen E Foster; Michael W Beresford
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

Review 3.  Treatment in juvenile rheumatoid arthritis and new treatment options.

Authors:  Özgür Kasapçopur; Kenan Barut
Journal:  Turk Pediatri Ars       Date:  2015-03-01

Review 4.  [Juvenile arthritides].

Authors:  G Horneff
Journal:  Z Rheumatol       Date:  2010-10       Impact factor: 1.372

Review 5.  Tumor necrosis factor inhibitors in the management of juvenile idiopathic arthritis: an evidence-based review.

Authors:  Susan Shenoi; Carol A Wallace
Journal:  Paediatr Drugs       Date:  2010-12-01       Impact factor: 3.022

6.  Challenges in the management of juvenile idiopathic arthritis with etanercept.

Authors:  Clare E Pain; Liza J McCann
Journal:  Biologics       Date:  2009-07-13

7.  Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.

Authors:  Matthew L Stoll; Alisa C Gotte
Journal:  Biologics       Date:  2008-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.